Cargando…

CD95/Fas promotes tumour growth

CD95 (also called Fas and APO-1) is a prototypical death receptor that regulates tissue homeostasis mainly in the immune system through induction of apoptosis 1-3. During cancer progression CD95 is frequently downregulated or cells are rendered apoptosis resistant 4,5 raising the possibility that lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lina, Park, Sun-Mi, Tumanov, Alexei V., Hau, Annika, Sawada, Kenjiro, Feig, Christine, Turner, Jerrold R., Fu, Yang-Xin, Romero, Iris, Lengyel, Ernst, Peter, Marcus E.
Formato:	Texto
Lenguaje:	English
Publicado:	2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879093/ https://www.ncbi.nlm.nih.gov/pubmed/20505730 http://dx.doi.org/10.1038/nature09075

Ejemplares similares

Signaling through the Death Receptor CD95 (APO-1/FAS)
por: Peter, Marcus E.
Publicado: (2001)

CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism
por: Guégan, Jean-Philippe, et al.
Publicado: (2021)

CD95/Fas ligand mRNA is toxic to cells
por: Putzbach, Will, et al.
Publicado: (2018)

CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
por: Le Gallo, Matthieu, et al.
Publicado: (2017)

Differential expression of Fas receptors (CD95) and Fas ligands (CD95L) in HIV infected and exposed uninfected children in Cameroon versus unexposed children
por: Dambaya, Béatrice, et al.
Publicado: (2019)

Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis
por: Gao, Yakun, et al.
Publicado: (1998)

Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma
por: Das, Satya N., et al.
Publicado: (2011)

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils
Publicado: (1996)

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
Publicado: (1995)

CD95/Fas ligand mRNA is toxic to cells through more than one mechanism
por: Haluck-Kangas, Ashley, et al.
Publicado: (2023)

Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression
por: Yamana, K, et al.
Publicado: (2005)

CD95 Is Part of a Let-7/p53/miR-34 Regulatory Network
por: Hau, Annika, et al.
Publicado: (2012)

Non-apoptotic Fas (CD95) Signaling on T Cells Regulates the Resolution of Th2-Mediated Inflammation
por: Williams, Jesse W., et al.
Publicado: (2018)

Ultraviolet Light Induces Apoptosis via Direct Activation of CD95 (Fas/APO-1) Independently of Its Ligand CD95L
por: Aragane, Yoshinori, et al.
Publicado: (1998)

Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
Publicado: (1994)

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice
Publicado: (1996)

Fas/CD95 Deficiency in Apc(Min/+) Mice Increases Intestinal Tumor Burden
por: Guillen-Ahlers, Hector, et al.
Publicado: (2010)

Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis
por: Bühling, Frank, et al.
Publicado: (2005)

Prognostic impact of apoptosis marker Fas (CD95) and its ligand (FasL) on bladder cancer in Egypt: study of the effect of schistosomiasis
por: Elmansy, HM, et al.
Publicado: (2012)

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
Publicado: (1996)

Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activation
por: Kober, A M M, et al.
Publicado: (2011)

Fas (CD95) expression in myeloid cells promotes obesity-induced muscle insulin resistance
por: Wueest, Stephan, et al.
Publicado: (2014)

Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction
por: Cruz, Anthony C., et al.
Publicado: (2016)

Apoptotic signalling targets the post-endocytic sorting machinery of the death receptor Fas/CD95
por: Sharma, Shruti, et al.
Publicado: (2019)

Fas/CD95 Signaling Pathway in Damage-Associated Molecular Pattern (DAMP)-Sensing Receptors
por: Galli, Gael, et al.
Publicado: (2022)

Transfer of Fas (CD95) protein from the cell surface to the surface of polystyrene beads coated with anti-Fas antibody clone CH-11
por: Sawai, H., et al.
Publicado: (2010)

Super-Resolution Imaging of Fas/CD95 Reorganization Induced by Membrane-Bound Fas Ligand Reveals Nanoscale Clustering Upstream of FADD Recruitment
por: Frazzette, Nicholas, et al.
Publicado: (2022)

CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells
por: Qadir, Abdul S., et al.
Publicado: (2021)

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
por: Kimura, M, et al.
Publicado: (1999)

Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)- mediated T cell apoptosis
Publicado: (1996)

Caspase cleavage of the Golgi stacking factor GRASP65 is required for Fas/CD95-mediated apoptosis
por: Cheng, J P X, et al.
Publicado: (2010)

Role of GD3-CLIPR-59 Association in Lymphoblastoid T Cell Apoptosis Triggered by CD95/Fas
por: Sorice, Maurizio, et al.
Publicado: (2010)

Pulmonary lesions and serum levels of soluble Fas (sCD95) in former hard coal miners
por: Hoffmeyer, F, et al.
Publicado: (2010)

The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis, driving cancer stemness in breast cancer
por: Qadir, Abdul S., et al.
Publicado: (2020)

p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
por: Müller, Martina, et al.
Publicado: (1998)

The Fas/CD95 Receptor Regulates the Death of Autoreactive B Cells and the Selection of Antigen-Specific B Cells
por: Koncz, Gabor, et al.
Publicado: (2012)

Modulation of Hippocampal Neuroplasticity by Fas/CD95 Regulatory Protein 2 (Faim2) in the Course of Bacterial Meningitis
por: Tauber, Simone C., et al.
Publicado: (2014)

Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia
por: Verlekar, Dattesh, et al.
Publicado: (2018)

Pathogen-Induced Proapoptotic Phenotype and High CD95 (Fas) Expression Accompany a Suboptimal CD8(+) T-Cell Response: Reversal by Adenoviral Vaccine
por: Vasconcelos, José Ronnie, et al.
Publicado: (2012)

Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma
por: Maruyama, R, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_5gr2mvrb9u2fge8macbt8umlk8